Once-daily piroxicam in rheumatoid arthritis: a double-blind cross-over comparison with aloxiprin.
作者信息
Roberts S D, Vir C, Porter K G
出版信息
Eur J Rheumatol Inflamm. 1981;4(3):323-31.
PMID:6086096
Abstract
摘要
相似文献
1
Once-daily piroxicam in rheumatoid arthritis: a double-blind cross-over comparison with aloxiprin.类风湿关节炎每日一次服用吡罗昔康：与阿洛昔普的双盲交叉对照比较。
Eur J Rheumatol Inflamm. 1981;4(3):323-31.
2
Piroxicam in the treatment of rheumatoid arthritis.吡罗昔康治疗类风湿性关节炎。
Eur J Rheumatol Inflamm. 1981;4(3):332-5.
3
A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
Eur J Rheumatol Inflamm. 1981;4(3):314-7.
4
A double blind comparison of piroxicam and enteric coated ASA in rheumatoid arthritis. A Cooperative Multicenter Canadian trial.
J Rheumatol. 1985 Feb;12(1):68-77.
5
Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study.吡罗昔康与萘普生治疗类风湿性关节炎的比较：一项双盲、交叉、多中心研究。
Eur J Rheumatol Inflamm. 1981;4(3):318-22.
6
A double-blind cross-over comparison of piroxicam mane and piroxicam nocte in osteoarthritis.吡罗昔康每日一次与吡罗昔康每晚一次治疗骨关节炎的双盲交叉对照研究。
Eur J Rheumatol Inflamm. 1981;4(3):336-41.
7
[Piroxicam in the treatment of rheumatoid arthritis].[吡罗昔康治疗类风湿关节炎]
Ter Arkh. 1988;60(4):128-30.
8
[Comparison of the effects of niflumic acid and aloxiprin in patients with progressive chronic rheumatoid arthritis in a double blind trial].[双盲试验中尼氟灭酸和阿洛昔普对进行性慢性类风湿关节炎患者疗效的比较]
Arzneimittelforschung. 1975 Aug;25(8):1308-11.
9
10
Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.依托度酸与吡罗昔康治疗类风湿性关节炎的双盲比较
Clin Ther. 1993 Jan-Feb;15(1):148-59.
引用本文的文献
1
Piroxicam: a review of its pharmacological properties and therapeutic efficacy.吡罗昔康：其药理特性与治疗效果综述
Drugs. 1981 Sep;22(3):165-87. doi: 10.2165/00003495-198122030-00001.
2
Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.吡罗昔康。对其药理学和治疗效果的重新评估。
Drugs. 1984 Oct;28(4):292-323. doi: 10.2165/00003495-198428040-00002.
Zotero 插件